Neoadjuvant as Future for Drug Development in Breast Cancer--Response

Affiliations

• ¹ University of Pennsylvania, Philadelphia, Pennsylvania. [email protected].
• ² University of Minnesota, Minneapolis, Minnesota.
• ³ QuantumLeap Healthcare Collaborative, San Francisco, California.
• ⁴ University of Texas MD Anderson Cancer Center, Houston, Texas.
• ⁵ University of California, San Francisco, San Francisco, California.